In addition, Ambra1 has been shown to modulate paclitaxel-induced apoptosis in breast cancer cells through the Bim/mitochondrial pathway, thereby altering the sensitivity of cells to paclitaxel27. Here, AMBRA1 is linked to breast carcinoma.